SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM

Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In other embodiments, the micr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FELDSTEIN, ROBERT, PELHAM, NY 10803, US, GLASS, JOHN, SHOREHAM, NY 11786, US, STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FELDSTEIN, ROBERT, PELHAM, NY 10803, US
GLASS, JOHN, SHOREHAM, NY 11786, US
STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US
description Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In other embodiments, the microparticles are stable at high pH and disintegrate at neutral or basic pH, or are stable at neutral pH and disintegrate at high or low pH. In the most preferred embodiment the microparticles are formed in the presence of the drug to be delivered, for example, insulin, felbamate, calcitonin or heparin. The diketopiperazine synthetic intermediates are preferably formed by cyclodimerization to form diketopiperazine derivatives at elevated temperatures under dehydrating conditions, functionalized on the side chains, and then precipitated with drug to be incorporated into microparticles.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE69301311TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE69301311TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE69301311TT23</originalsourceid><addsrcrecordid>eNrjZLAPdvVxCg7RdXR39_H3dQ3ydA1y9XNxDVZw8fR2DfEP8AxwDXKM8vTTdQyK8nP1DA7xd3NzdHJ3dHINjgwOcfXlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxLq5mlsYGhsaGhiEhRsZEKQIAQFIr8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM</title><source>esp@cenet</source><creator>FELDSTEIN, ROBERT, PELHAM, NY 10803, US ; GLASS, JOHN, SHOREHAM, NY 11786, US ; STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</creator><creatorcontrib>FELDSTEIN, ROBERT, PELHAM, NY 10803, US ; GLASS, JOHN, SHOREHAM, NY 11786, US ; STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</creatorcontrib><description>Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In other embodiments, the microparticles are stable at high pH and disintegrate at neutral or basic pH, or are stable at neutral pH and disintegrate at high or low pH. In the most preferred embodiment the microparticles are formed in the presence of the drug to be delivered, for example, insulin, felbamate, calcitonin or heparin. The diketopiperazine synthetic intermediates are preferably formed by cyclodimerization to form diketopiperazine derivatives at elevated temperatures under dehydrating conditions, functionalized on the side chains, and then precipitated with drug to be incorporated into microparticles.</description><edition>6</edition><language>ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960822&amp;DB=EPODOC&amp;CC=DE&amp;NR=69301311T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960822&amp;DB=EPODOC&amp;CC=DE&amp;NR=69301311T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FELDSTEIN, ROBERT, PELHAM, NY 10803, US</creatorcontrib><creatorcontrib>GLASS, JOHN, SHOREHAM, NY 11786, US</creatorcontrib><creatorcontrib>STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</creatorcontrib><title>SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM</title><description>Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In other embodiments, the microparticles are stable at high pH and disintegrate at neutral or basic pH, or are stable at neutral pH and disintegrate at high or low pH. In the most preferred embodiment the microparticles are formed in the presence of the drug to be delivered, for example, insulin, felbamate, calcitonin or heparin. The diketopiperazine synthetic intermediates are preferably formed by cyclodimerization to form diketopiperazine derivatives at elevated temperatures under dehydrating conditions, functionalized on the side chains, and then precipitated with drug to be incorporated into microparticles.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPdvVxCg7RdXR39_H3dQ3ydA1y9XNxDVZw8fR2DfEP8AxwDXKM8vTTdQyK8nP1DA7xd3NzdHJ3dHINjgwOcfXlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxLq5mlsYGhsaGhiEhRsZEKQIAQFIr8g</recordid><startdate>19960822</startdate><enddate>19960822</enddate><creator>FELDSTEIN, ROBERT, PELHAM, NY 10803, US</creator><creator>GLASS, JOHN, SHOREHAM, NY 11786, US</creator><creator>STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</creator><scope>EVB</scope></search><sort><creationdate>19960822</creationdate><title>SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM</title><author>FELDSTEIN, ROBERT, PELHAM, NY 10803, US ; GLASS, JOHN, SHOREHAM, NY 11786, US ; STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE69301311TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1996</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FELDSTEIN, ROBERT, PELHAM, NY 10803, US</creatorcontrib><creatorcontrib>GLASS, JOHN, SHOREHAM, NY 11786, US</creatorcontrib><creatorcontrib>STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FELDSTEIN, ROBERT, PELHAM, NY 10803, US</au><au>GLASS, JOHN, SHOREHAM, NY 11786, US</au><au>STEINER, SOLOMON S., MOUNT KISCO, NY 10549, US</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM</title><date>1996-08-22</date><risdate>1996</risdate><abstract>Drug delivery systems have been developed based on the formation of diketopiperazine (or analogs) microparticles. In the preferred embodiment the microparticle is stable at low pH and disintegrates at physiological pH, and is particularly useful for oral drug delivery. In other embodiments, the microparticles are stable at high pH and disintegrate at neutral or basic pH, or are stable at neutral pH and disintegrate at high or low pH. In the most preferred embodiment the microparticles are formed in the presence of the drug to be delivered, for example, insulin, felbamate, calcitonin or heparin. The diketopiperazine synthetic intermediates are preferably formed by cyclodimerization to form diketopiperazine derivatives at elevated temperatures under dehydrating conditions, functionalized on the side chains, and then precipitated with drug to be incorporated into microparticles.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_DE69301311TT2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SELBST-AGGLOMERIERENDES DIKETOPIPERAZIN-ARZNEISTOFFABGABESYSTEM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FELDSTEIN,%20ROBERT,%20PELHAM,%20NY%2010803,%20US&rft.date=1996-08-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE69301311TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true